News

Velocity Wins the 2024 Vaccine Industry Excellence Award for Best Clinical Trial Company

Velocity has won the 2024 Vaccine Industry Excellence (ViE) award for Best Clinical Trial Company at The World Vaccine Congress in Washington, DC. The recognition is based on performance metrics, diversity of vaccine trial capabilities, and key initiatives to support vaccine research. Highlights of our groundbreaking initiatives and achievements throughout the past year include: The … Read more

Exploring the Power of Scale in Patient Recruitment: A Recap of the Velocity and HealthMatch Presentation at SCOPE

Last month, Nick Spittal, Velocity’s chief operating officer announced the company’s latest partnership with HealthMatch and results from an unprecedented patient recruitment pilot at the SCOPE conference in Orland, Florida. He was joined by HealthMatch CEO, Manuri Gunawardena, on stage for a joint presentation, as Clinical Trials Report journalist Michael Causey reports: Velocity announced its … Read more

Velocity Hosts Global CARE Council Summit

Velocity recently convened more than 40 leaders from around the world for a summit on Councils to Accelerate Research Excellence (CARE). Each CARE Council comprises key opinion leaders, Principal Investigators, and operational experts from Velocity sites worldwide. The summit focused on Velocity’s Diabetes + Obesity, MASH, Vaccine, Cardiology, and Women’s Health CARE Councils, along with … Read more

Doctor Finds ‘Energizing’ Second Career as PI

It’s easy to hear the enthusiasm for clinical trials when William Cromwell, MD, FAHA, FNLA, Principal Investigator and a leader of the Velocity Cardiometabolic CARE Council, discusses their importance to patients yesterday, today, and tomorrow.  Dr. Cromwell is board-certified in Family Medicine and Clinical Lipidology with over 20 years of clinical research experience.  As he … Read more

Video: AI-Enabled Technology

Despite a boom in tech funding and monumental advancements in AI/ML and in silico models, tech advancements have not yet translated into marked efficiency improvements at clinical research sites. Most clinical trials still fail to meet enrollment timelines, with most delays occurring at the site level. To gain efficiency, technology must enhance clinical trials at … Read more

Podcast: Celebrating Excellence in Patient Centricity (With Sanofi and SCRS)

“[Patient centricity] is about taking those patient insights and their voice and translating them into actions. And that was really the impetus for what we saw in Velocity’s submission.” – Pat Roselle, Global Head of Patient Stakeholder Engagement at Sanofi. Thank you to Pat and Jimmy Bechtel for joining Nick Spittal to discuss the initiatives … Read more

Video: Global Laboratory Capabilities

As part of our integrated site infrastructure, Velocity has established specialized laboratory and diagnostic capabilities. This includes purpose-built, CLIA-certified lab facilities at all dedicated sites, as well as in-network PBMC processing at 30+ Velocity locations across the U.S. and Europe. As Nick Spittal, Chief Operations Officer, explains in this video, Velocity is also using these … Read more

Therapeutic Area Thursday Webinars: Enhancing Specialty Trial Support Through Expert Knowledge Sharing

How can one specialist’s deep therapeutic expertise transform the way 90+ sites worldwide operate and engage patients? In the past month, Nadege Gunn, MD, CPI, gave an insightful internal presentation on MASH. A renowned expert in gastroenterology and hepatology, Dr. Gunn shared her invaluable expertise, drawing from her extensive experience in bridging clinical trials with … Read more

Video: Principal Investigator Experience and Engagement

About half of Principal Investigators (PIs) conduct only a single study in their career. This high turnover rate results in significant inefficiencies for Sponsors and CROs, particularly when it comes to finding reliable PIs capable of delivering high-quality trial conduct and enrollment in specialized research areas.

Velocity developed the innovative Principal Investigator Onboarding and Training (PIVOT) Program to address the pressing issue of “one-and-done” PIs in clinical research. This strategic initiative equips new PIs with comprehensive knowledge, tools, infrastructure, and mentorship opportunities.

The PIVOT Program:

  • Elevates PI engagement, performance, and retention through a novel curriculum
  • Combines industry leading training content, hands-on experiences, and mentorship
  • Specific training tracks for full-time PIs and specialist PIs with embedded operations

Learn more at https://velocityclinical.com/investigator-expertise

Velocity Joins the IQVIA Connected Research Community in Europe

Velocity is proud to be a part of IQVIA’s Prime and Partner Site Programme. IQVIA have created a joint innovation group with representatives from their elite network of Prime and Super Partner sites across Europe, known as the “IQVIA Connected Research Community”. The purpose is to share ideas, lessons-learned, challenges, and innovations across our sites and … Read more